Announced Fri, 13 Feb · 15:22 IST

Vijaya Diagnostic Centre Limited has informed the Exchange regarding Appointment of Mr Ankit Shah as Chief Financial Officer of the company w.e.f. February 13, 2026.

Cfo ResignedKmp ResignedManagement Changes View source PDF

VIJAYA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vijaya Diagnostic Centre's board, at its meeting on February 13, 2026, approved the unaudited Q3 FY26 (ended Dec 31, 2025) standalone and consolidated financial results. Mr. S. Ramachandra Reddy stepped down as Chief Financial Officer due to organizational restructuring, but will continue as General Manager – Finance & Accounts. Mr. Ankit Shah, a Chartered Accountant and former Group CFO at Incor Hospitals (OMNI Hospitals), was appointed as the new CFO effective the same date. Two new Non-Executive Independent Directors — senior advocate Mr. Ravi Shankararamiah (DIN 00180746) and senior gynaecologist Dr. Sasikala Paruchuri Kola (DIN 00129614) — were appointed for 5-year terms, subject to shareholder approval. The board also appointed Mr. Sai Prasad (ex-UnitedHealth/Optum) as CTO and Mr. Siva Rama Raju Vegesna (ex-KIMS Hospitals and a former Vijaya employee) as COO. Additionally, 1,15,000 ESOPs were granted at ₹809 per option (a 20% discount to the 3-month average) under the VDCL ESOP Plan 2018, and the Related Party Transaction policy was revised per the latest SEBI framework.

Likely market impact

This is a broad leadership refresh rather than a distress signal — the outgoing CFO stays on, and the new C-suite brings strong healthcare, technology and capital markets expertise. The addition of two experienced independent directors (legal and medical) should strengthen board oversight. Investors should focus on the Q3 results for actual business performance, as leadership transitions are well-managed.